The Teachings of Dr. Charles Stanley on In Touch+ are Now Available in 90 Broadcast Markets SCOTTSDALE, Ariz., Nov. 5, 2025 /PRNewswire/ -- In Touch+, the trusted source of biblical teachings from In ...
California wildlife officials have tried bean bag guns, loud music and drones. Now they're resorting to killing an endangered ...
They still talk about their commitment to excellence, their great achievements, their leadership of the world of science, but ...
SCOTUSblog on MSNOpinion
Being a justice doesn’t make you a policy expert
Please note that the views of outside contributors do not reflect the official opinions of SCOTUSblog or its staff. Lawyers ...
Objective Response Rate (ORR) reported for bezuclastinib combination compared to 26% ORR for sunitinib monotherapy (p<0.0001) Safety profile of bezuclastinib combination was well tolerated with no ...
Vendors made their agentic ambitions clear this fall - but the role of partners? Not so much. Oracle AI World was an ...
Explore the best crypto presales to buy for November, spotlighting BullZilla, Bonk, and MoonBull, three meme powerhouses ...
Trump has cast the H-2A program as a quick help for farmers. At the same time, the program has been suspended during the government shutdown, which could cause production problems.
Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors November 8:00 ...
Apex predators capture the imagination of the outdoors wherever they’re found. We humans have tipped the scales in our favor through brains and tools to stay on top and out of the jaws of everything ...
Phase 3 PEAK results in 2nd-line GIST patients expected in November; pivotal APEX results in AdvSM patients expected in December Breakthrough Therapy Designation granted for bezuclastinib; New Drug Ap ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback